Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised studyGiancarlo Comi, O. R. Hommes, Pierrette Seeldrayers et al.|The Lancet|2001Cited by 1.1k
Multiple sclerosis registries in Europe – An updated mapping surveyAnna Glaser, Christoph Thalheim, Rod Middleton et al.|Multiple Sclerosis and Related Disorders|2018Cited by 67
The Multiple Sclerosis Data Alliance CatalogueLotte Geys, Liesbet M. Peeters, Mikołaj A. Pawlak et al.|International Journal of MS Care|2021Cited by 11
Long‐Term Safety of Teriflunomide in Multiple Sclerosis Patients: Results of Prospective Comparative Studies in Three European CountriesMelinda Magyari, Philippe Autier, Stéphanie Polazzi et al.|Pharmacoepidemiology and Drug Safety|2024Cited by 3